First Multiple Sclerosis Pill approved by FDA
Posted on September 28, 2010 by Jeffrey Newman
Last week, Novartis received FDA approval to market the once a day pill Gilenya, a sphingosine 1-phosphate receptor modulator for treatment of multiple sclerosis. Other MS treatments require injection. The precise mechanism of action is not understood in MS but seems to act by reducing the release of white cells from lymph nodes thereby reducing […]